A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

Clinical trial NCT05711667 · RECRUITING

Trial details

NCT number: NCT05711667
Sponsor: Children's Oncology Group
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm

Start date: 2024-07-11
Primary completion: 2029-06-30
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.